Table 5.
Medical costs and resource utilization from date of transplant hospitalization to day 100 post-transplantation by age at transplantation for selected diagnoses
| Cost category | Age at transplant | |
|---|---|---|
| ≤ 20 years | > 20 years | |
| Autologous HCT for lymphoma | ||
| Sample size | 27 | 568 |
| Number of hospitalizations, median (range) | 1 (1–4) | 1 (1–5) |
| Total days hospitalized, median (IQR) | 22 (19–29) | 20 (18–24) |
| Number of outpatient clinic visits, median (range) | 13 (9–19) | 11 (7–18) |
| Total costs, median (IQR) | $117,674 (100,879–152,241) | $102,458 (79,053–140,529) |
| Total outpatient costs, median (IQR) | $11,016 (6,217–25,759) | $7,941 (3,109–17,449) |
| Total inpatient costs, median (IQR) | $101,945 (79,630–136,860) | $90,157 (69,863–125,482) |
| Costs for HCT hospitalization, median (IQR) | $90,727 (71,111–111,503) | $86,051 (66,861–115,439) |
| Costs for subsequent hospitalization, median (IQR) | $0 (0–13,942) | $0 (0-0) |
| Autologous HCT for multiple myeloma | ||
| Sample size | -- | 791 |
| Number of hospitalizations, median (range) | -- | 1 (1–5) |
| Total days hospitalized, median (IQR) | -- | 16 (14–20) |
| Number of outpatient clinic visits, median (range) | -- | 12 (8–18) |
| Total costs, median (IQR) | -- | $90,702 (67,213–119,894) |
| Total outpatient costs, median (IQR) | -- | $6,767 (2,840–13,264) |
| Total inpatient costs, median (IQR) | -- | $80,789 (56,809–107,292) |
| Costs for HCT hospitalization, median (IQR) | -- | $77,665 (54,833–102,072) |
| Costs for subsequent hospitalization, median (IQR) | -- | $0 (0-0) |
| Allogeneic HCT for AML, ALL and MDS | ||
| Sample size | 113 | 610 |
| Number of hospitalizations, median (range) | 2 (1–5) | 1 (1–5) |
| Total days hospitalized, median (IQR) | 43 (34–54) | 30 (24–42) |
| Number of outpatient clinic visits, median (range) | 20 (14–30) | 22 (13–32) |
| Total costs, median (IQR) | $302,822 (211,532–454,747) | $191,142 (137,752–286,097) |
| Total outpatient costs, median (IQR) | $31,463 (16,301–49,990) | $19,138 (8,769–39,125) |
| Total inpatient costs, median (IQR) | $254,485 (176,671–409,995) | $164,825 (116,576–250,468) |
| Costs for HCT hospitalization, median (IQR) | $200,000 (155,024–335,909) | $145,343 (107,978–206,978) |
| Costs for subsequent hospitalization, median (IQR) | $3,817 (0-0–34,162) | $0 (0–22,339) |
HCT – hematopoietic cell transplantation; IQR – interquartile range; AML – acute myeloid leukemia; ALL – acute lymphoblastic leukemia; MDS – myelodysplastic syndrome